To further validate the ferroptosis-mediated synthetic lethality of ARID1A and c-MET, we established another ARID1A-isogenic cell model derived from the RKO CRC cell line, which has a frameshift mutation in ARID1A [30]. This evidence concerns the gene MET and colorectal carcinoma.